Impact of pharmacist counselling on clozapine knowledge

Show simple item record

dc.contributor.author Ní Dhubhlaing, Ciara
dc.contributor.author Young, Ailish
dc.contributor.author Sahm, Laura J.
dc.date.accessioned 2018-06-15T11:47:13Z
dc.date.available 2018-06-15T11:47:13Z
dc.date.issued 2017
dc.identifier.citation Ní Dhubhlaing, C., Young, A. and Sahm, L. J. (2017) 'Impact of pharmacist counselling on clozapine knowledge', Schizophrenia Research and Treatment, 2017, 6120970 (9pp). doi: 10.1155/2017/6120970 en
dc.identifier.volume 2017
dc.identifier.startpage 1
dc.identifier.endpage 8
dc.identifier.issn 2090-2085
dc.identifier.uri http://hdl.handle.net/10468/6335
dc.identifier.doi 10.1155/2017/6120970
dc.description.abstract Clozapine is the only antipsychotic with evidence for efficacy in treatment of resistant schizophrenia but it carries a high side effect burden. Patient information is provided but may be poorly retained. This study aims to examine the impact of pharmacist counselling upon patient knowledge of clozapine. Outpatients, aged 18 years and over, attending St. Patrick's University Hospital, Dublin, participated in this study between June and August 2015. The intervention consisted of pharmacist counselling on two occasions one month apart. Knowledge was assessed using a 28-point checklist devised from the currently available clozapine patient information sources, at baseline and after each counselling session. Ethics approval was obtained. Twenty-five participants (40% female; mean age 45.1 years, SD 9.82; 64% unemployed, 28% smokers) showed an improvement in knowledge scores of clozapine from baseline to postcounselling on each occasion with an overall improvement in knowledge score, from baseline to postcounselling at one month, of 39.43%; p < 0.001. This study adds to the evidence that interventions involving pharmacist counselling can improve patient knowledge, whilst the specific knowledge gained relating to recognition of side effects may help patients towards more empowerment regarding their treatment. en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher Hindawi Ltd en
dc.relation.uri https://www.hindawi.com/journals/schizort/2017/6120970
dc.rights © 2017, Ciara Ní Dhubhlaing et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. en
dc.rights.uri https://creativecommons.org/licenses/by/4.0/
dc.subject Health literacy en
dc.subject Schizophrenia en
dc.subject Meta-analysis en
dc.subject Adherence en
dc.subject Awareness en
dc.subject Patient en
dc.subject Risk en
dc.title Impact of pharmacist counselling on clozapine knowledge en
dc.type Article (peer-reviewed) en
dc.internal.authorcontactother Laura Sahm, Pharmacy, University College Cork, Cork, Ireland. +353-21-490-3000 Email: l.sahm@ucc.ie en
dc.internal.availability Full text available en
dc.description.version Published Version en
dc.description.status Peer reviewed
dc.identifier.journaltitle Schizophrenia Research and Treatment en
dc.internal.IRISemailaddress l.sahm@ucc.ie en
dc.identifier.articleid UNSP 6120970


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2017, Ciara Ní Dhubhlaing et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Except where otherwise noted, this item's license is described as © 2017, Ciara Ní Dhubhlaing et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement